STERIS Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
STERIS heeft een totaal eigen vermogen van $6.6B en een totale schuld van $2.2B, wat de schuld-eigenvermogensverhouding op 32.6% brengt. De totale activa en totale passiva bedragen respectievelijk $10.2B en $3.6B. De EBIT STERIS is $954.3M waardoor de rentedekking 8.3 is. Het heeft contanten en kortetermijnbeleggingen van $172.2M.
Belangrijke informatie
32.6%
Verhouding schuld/eigen vermogen
US$2.16b
Schuld
| Rente dekkingsratio | 8.3x |
| Contant | US$172.20m |
| Aandelen | US$6.61b |
| Totaal verplichtingen | US$3.63b |
| Totaal activa | US$10.24b |
Recente financiële gezondheidsupdates
Is STERIS (NYSE:STE) A Risky Investment?
Oct 01
Is STERIS (NYSE:STE) Using Too Much Debt?
Jun 13STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Recent updates
What Does STERIS plc's (NYSE:STE) Share Price Indicate?
Oct 19Is STERIS (NYSE:STE) A Risky Investment?
Oct 01Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued
Sep 16Earnings Tell The Story For STERIS plc (NYSE:STE)
Sep 13Steris: Q2 Numbers Solidify Buy Thesis
Aug 13STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price
Aug 08When Should You Buy STERIS plc (NYSE:STE)?
Jul 04Is STERIS (NYSE:STE) Using Too Much Debt?
Jun 13Steris: Moving On, Losing Its Teeth
Apr 14STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price
Mar 29STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07Steris: Strong Healthcare Products Growth Coupled With Weak AST Business
Feb 17STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't
Feb 15An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued
Dec 17Should You Investigate STERIS plc (NYSE:STE) At US$203?
Nov 24Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes
Nov 08We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?
Sep 18Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage
Sep 01When Should You Buy STERIS plc (NYSE:STE)?
Aug 10Steris: Continuing To Grow The Product Lineup
Jun 20Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered
Feb 09Steris declares $0.47 dividend
Feb 01These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)
Dec 28Steris declares $0.47 dividend
Nov 02STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Steris: Non-GAAP Valuations Supportive Of Substantial Upside
Sep 04STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47
Aug 18STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47
Aug 04Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M
Aug 02Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $1.9B ) STE } overtreffen de korte termijn passiva ( $805.5M ).
Langlopende schulden: De kortetermijnactiva van STE ( $1.9B ) dekken de langetermijnschulden ( $2.8B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 30% ) STE wordt als voldoende beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van STE is de afgelopen 5 jaar gedaald van 36.7% naar 32.6%.
Schuldendekking: De schuld van STE wordt goed gedekt door de operationele kasstroom ( 51% ).
Rentedekking: De rentebetalingen op de schuld van STE worden goed gedekt door EBIT ( 8.3 x dekking).